Grow lab models of head and neck cancer to test treatments
Part of Cancer clinical trials.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have squamous cell cancer of the mouth, throat (oropharynx/hypopharynx), or voice box (larynx)
- Your cancer should be newly diagnosed and planned for surgery (no prior treatment)
- Have a stage pattern that fits T3 or T4, or T2 with lymph node involvement (N+)
- Be able to participate through the usual social security system and agree to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This study looks at the genetic information in your tumor to find new ways to treat head and neck cancer. You'll get extra biopsies and blood tests, and your genetic data will be shared with researchers to help personalize future treatments.
This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This study looks at the natural bacteria in and around head and neck tumors compared to healthy tissue. The goal is to understand if these bacteria affect cancer growth and treatment. By participating, you help researchers learn more about this type of cancer.
This trial looks for specific signs in your blood and tumor tissue that may show how well immunotherapy is working for recurrent or metastatic head and neck cancer. It aims to help doctors personalize treatment in the future.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.